Literature DB >> 9729735

Antibody engineering.

W Dall'Acqua1, P Carter.   

Abstract

Among the most important advances in antibody engineering of this past year is the advent of new tools to study the relationship between protein (including antibody) structure and function. Very rapid large-scale mutational analysis of antibodies is now possible by using in vitro transcription and translation. Ribosome display is a rapidly evolving technology for modifying antibody function that offers several potential advantages over phage display.

Mesh：

Substances：

Year:  1998        PMID： 9729735     DOI： 10.1016/s0959-440x(98)80121-8

Source DB:  PubMed          Journal:  Curr Opin Struct Biol        ISSN： 0959-440X            Impact factor:   6.809


  12 in total

1.  Ophthalmology in the post-genomic era.

Authors:  G C Black; M E Boulton; P N Bishop; D McLeod
Journal:  Br J Ophthalmol       Date:  1999-11       Impact factor: 4.638

2.  Making artificial antibodies: a format for phage display of combinatorial heterodimeric arrays.

Authors:  C Gao; S Mao; C H Lo; P Wirsching; R A Lerner; K D Janda
Journal:  Proc Natl Acad Sci U S A       Date:  1999-05-25       Impact factor: 11.205

Review 3.  Generation and production of engineered antibodies.

Authors:  Sergey M Kipriyanov; Fabrice Le Gall
Journal:  Mol Biotechnol       Date:  2004-01       Impact factor: 2.695

4.  A method for the generation of combinatorial antibody libraries using pIX phage display.

Authors:  Changshou Gao; Shenlan Mao; Gunnar Kaufmann; Peter Wirsching; Richard A Lerner; Kim D Janda
Journal:  Proc Natl Acad Sci U S A       Date:  2002-09-18       Impact factor: 11.205

5.  A novel bispecific antibody, BiSS, with potent anti-cancer activities.

Authors:  Bin Dong; Changhua Zhou; Ping He; Jing Li; Siqi Chen; Ji Miao; Qing Li; Zhong Wang
Journal:  Cancer Biol Ther       Date:  2016-02-01       Impact factor: 4.742

6.  QTY code designed thermostable and water-soluble chimeric chemokine receptors with tunable ligand affinity.

Authors:  Rui Qing; Qiuyi Han; Michael Skuhersky; Haeyoon Chung; Myriam Badr; Thomas Schubert; Shuguang Zhang
Journal:  Proc Natl Acad Sci U S A       Date:  2019-11-27       Impact factor: 11.205

7.  Tumor targeting by a multivalent single-chain Fv (scFv) anti-Lewis Y antibody construct.

Authors:  Marcus P Kelly; F-T Lee; Kiki Tahtis; Barbara E Power; Fiona E Smyth; Martin W Brechbiel; Peter J Hudson; Andrew M Scott
Journal:  Cancer Biother Radiopharm       Date:  2008-08       Impact factor: 3.099

Review 8.  Preclinical safety testing of biotechnology-derived pharmaceuticals: understanding the issues and addressing the challenges.

Authors:  Frank R Brennan; Leigh Shaw; Mark G Wing; Christine Robinson
Journal:  Mol Biotechnol       Date:  2004-05       Impact factor: 2.860

9.  Generation and Characterization of an scFv Directed against Site II of Rabies Glycoprotein.

Authors:  Shukra M Aavula; Sridevi V Nimmagadda; Neelakantam Biradhar; Samuel Sula; Dev Chandran; Rajendra Lingala; Srinivasan Alwar Villuppanoor
Journal:  Biotechnol Res Int       Date:  2011-10-05

10.  Selection of diethylstilbestrol-specific single-chain antibodies from a non-immunized mouse ribosome display library.

Authors:  Yanan Sun; Baoan Ning; Ming Liu; Xianjun Gao; Xianjun Fan; Jianqing Liu; Zhixian Gao
Journal:  PLoS One       Date:  2012-03-13       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.